ULURU INC. ANNOUNCES ADDITIONAL DATA SUPPORTING ALTRAZEAL® USE IN DIABETIC FOOT ULERS

10/27/2011

Addison, Texas, October 27, 2011; ULURU Inc. (NYSE AMEX: ULU), today announced that additional data supporting the use of Altrazeal® in the treatment of Wagner Grade 2 diabetic foot ulcers was presented at a recent medical conference. Read More